Literature DB >> 4392540

Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.

J M Kofi Ekue, D C Lowe, R G Shanks.   

Abstract

1. Propranolol, a beta-adrenoceptor blocking drug with local anaesthetic and a direct myocardial depressant action, and MJ 1999, a beta-adrenoceptor blocking drug which has no local anaesthetic or intrinsic sympathomimetic action, were compared for beta-adrenoceptor blocking activity in man.2. Propranolol was 2.67 times more active than MJ 1999 in reducing by 50% the tachycardia produced by the intravenous infusion of isoprenaline in healthy volunteers.3. Propranolol and MJ 1999 intravenously both reduced resting heart rate in the standing position and an exercise tachycardia, but there was no qualitative or quantitative difference between them.4. On oral administration, both propranolol and MJ 1999 reduced resting heart rate and an exercise induced tachycardia; propranolol was only slightly more active than MJ 1999.5. In patients with thyrotoxicosis propranolol was about twice as active as MJ 1999 in reducing the heart rate.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4392540      PMCID: PMC1702574          DOI: 10.1111/j.1476-5381.1970.tb10596.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  THE EFFECTS ON CARDIAC MUSCLE OF BETA-RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS.

Authors:  A MORALES AGUILERA; E M VAUGHANWILLIAMS
Journal:  Br J Pharmacol Chemother       Date:  1965-04

2.  Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.

Authors:  P M Lish; J H Weikel; K W Dungan
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

3.  Inotropic and chronotropic effects of a series of beta-adrenergic blocking drugs: some structure-activity relationships.

Authors:  J V Levy; V Richards
Journal:  Proc Soc Exp Biol Med       Date:  1966-06

4.  Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties.

Authors:  J V Levy
Journal:  Eur J Pharmacol       Date:  1968-02       Impact factor: 4.432

5.  Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise.

Authors:  I Brick; K J Hutchison; D G McDevitt; I C Roddie; R G Shanks
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

6.  Inhibition of cardiac chronotropic action of isoproterenol by Sotalol (MJ 1999) in rat, dog and man.

Authors:  P M Lish; M V Shelanski; J A LaBudde; W R Williams
Journal:  Curr Ther Res Clin Exp       Date:  1967-06

7.  Sotalol: a new, safe beta adrenergic receptor blocking agent.

Authors:  W S Frankl; L A Soloff
Journal:  Am J Cardiol       Date:  1968-08       Impact factor: 2.778

8.  A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia.

Authors:  P Turner; R C Hill
Journal:  J Clin Pharmacol J New Drugs       Date:  1968 Jul-Aug

9.  Effect of beta adrenergic blockade on the hemodynamic responses to epinephrine in man.

Authors:  W S Harris; C D Schoenfeld; R H Brooks; A M Weissler
Journal:  Am J Cardiol       Date:  1966-04       Impact factor: 2.778

10.  Potency and time-effect relationship in man of propranolol and H 56-28--comparative studies after oral administration.

Authors:  B Ablad; G Johnsson; A Norrby; L Sölvell
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1967
View more
  12 in total

1.  Adrenergic beta-receptor blockade in hyperthyroidism.

Authors:  I Ramsay
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

2.  Observations on the efficacy and pharmacokinetics of sotalol after oral administration.

Authors:  H C Brown; S G Carruthers; J G Kelly; D G McDevitt; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

3.  Beta-adrenergic blocking drugs and thyroid function.

Authors: 
Journal:  Br Med J       Date:  1977-10-22

4.  Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.

Authors:  T Ishizaki; K Tawara
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

5.  Intrinsic heart rate on exercise and the measurement of beta-adrenoceptor blockade.

Authors:  S G Carruthers; R G Shanks; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

6.  Alprenolol and propranolol in hyperthyroid tachycardia.

Authors:  P Turner
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

Review 7.  Beta-adrenergic receptor blocking drugs in hyperthyroidism.

Authors:  P Turner
Journal:  Drugs       Date:  1974       Impact factor: 9.546

8.  Comparison of propranolol and Ro 3-3528 in hyperthyroid tachycardia and dysrhythmias.

Authors:  E M Phillips; P Turner; J Houghton; D G Ferriman
Journal:  Postgrad Med J       Date:  1973-01       Impact factor: 2.401

9.  Comparison of propranolol and LB 46 (prinodolol) on hyperthyroid tachycardia.

Authors:  A G Arbab; P Turner
Journal:  Postgrad Med J       Date:  1971-06       Impact factor: 2.401

10.  A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.